Filtered By:
Specialty: Endocrinology
Drug: Fortamet
Countries: Spain Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 1 results found since Jan 2013.
A Multinational Real-World Study on the Clinical Characteristics of Patients with Type 2 Diabetes Initiating Dapagliflozin in Southern Europe
ConclusionsSignificant differences were seen among patients initiating dapagliflozin in southern Europe. Our results suggest that dapagliflozin was being initiated at different stages of the disease according to the country and prescribing settings. Such geographic heterogeneity may have an impact upon effectiveness of dapagliflozin on glucose lowering, as well as cardiovascular and renal outcomes.
Source: Diabetes Therapy - December 19, 2019 Category: Endocrinology Source Type: research
